Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WELL Health Technologies Corp ( (TSE:WELL) ) has provided an announcement.
WELL Health Technologies Corp’s subsidiary, WELLSTAR, has achieved significant growth through both organic and inorganic means. OceanMD, a leader in Canada’s eReferral market, has secured a major contract with a Canadian province, boosting WELLSTAR’s annual recurring revenue by 16%. Additionally, WELLSTAR has completed several strategic acquisitions and raised $62 million to support its growth initiatives, positioning itself as a premier digital health platform in Canada.
The most recent analyst rating on (TSE:WELL) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on WELL Health Technologies Corp stock, see the TSE:WELL Stock Forecast page.
Spark’s Take on TSE:WELL Stock
According to Spark, TipRanks’ AI Analyst, TSE:WELL is a Neutral.
The overall stock score for WELL Health Technologies Corp is primarily influenced by strong revenue growth and positive earnings call sentiment. However, significant challenges in profitability, cash flow management, and technical indicators contribute to a lower score. The negative P/E ratio and lack of dividend yield further impact the valuation negatively.
To see Spark’s full report on TSE:WELL stock, click here.
More about WELL Health Technologies Corp
WELL Health Technologies Corp is a digital healthcare company that focuses on enhancing health outcomes by leveraging technology to empower healthcare practitioners and patients globally.
Average Trading Volume: 1,403,205
Technical Sentiment Signal: Sell
Current Market Cap: C$1.06B
For an in-depth examination of WELL stock, go to TipRanks’ Overview page.